Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Newport, G.
Right arrow Articles by Agabian, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Newport, G.
Right arrow Articles by Agabian, N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 272, Number 46, Issue of November 14, 1997 pp. 28954-28961

KEX2 Influences Candida albicans Proteinase Secretion and Hyphal Formation*

(Received for publication, May 7, 1997, and in revised form, August 6, 1997)

George Newport Dagger and Nina Agabian Dagger §par

From the Departments of Dagger  Stomatology, § Pharmaceutical Chemistry, and  Microbiology & Immunology, University of California at San Francisco, San Francisco, California 94143-0422

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES


ABSTRACT

Candida albicans possesses at least seven differentially expressed genes that encode virulence-related secretory aspartyl proteinases (Saps). Sap DNA sequences predict post-translational processing at lysine-arginine residues in the preproteins, reminiscent of the maturation of Saccharomyces cerevisiae alpha -factor, where a prepropolypeptide is converted into a biologically active pheromone by Kex2, a subtilisin-like proprotein convertase. To investigate involvement of a C. albicans KEX2 homologue in Sap activation, a genetic selection was performed based on KEX2 function. A kex2 strain of S. cerevisiae was transformed with a C. albicans genomic DNA library and screened for the production of active alpha -factor. Positive clones were assayed for killer toxin activity, another Kex2-dependent phenotype. Plasmids that rescued both defects contained a sequence encoding a protein homologous to S. cerevisiae Kex2. Both alleles of the C. albicans KEX2 were inactivated by successive mutations. Null mutants continued to secrete active Sap2; however, the enzyme was abnormally processed and secreted at reduced levels. Unexpectedly, null mutants were incapable of forming hyphae, instead differentiating into aberrantly shaped cells. The ability to normally process Sap2 and form hyphae was restored upon transformation of null mutants with a KEX2-containing plasmid.


INTRODUCTION

Candida albicans is an asexual, diploid yeast that normally colonizes the lumen of the alimentary tract and/or vagina of humans. Although usually commensal, it is increasingly important as an opportunistic pathogen, becoming invasive and causing significant morbidity in individuals who are immunocompromised (1). The secretion of aspartyl proteinases (Saps)1 encoded by at least seven genes in C. albicans, is considered to be an important virulence attribute in the opportunistic setting (2-4), along with a high rate of phenotypic switching (5), an enhanced ability to adhere to relevant surfaces (6, 7), and greater tolerance to anti-fungal drugs (8).

The C. albicans Saps have been implicated in tissue invasion, adhesion, and interference with specific and nonspecific host defense systems (9-12). They resemble pepsin in structure, have broad substrate specificity, and are reproducibly induced by growth in media where protein is the sole nitrogen source (13, 14). SAP gene expression is correlated with the organism's yeast to hyphae transition as well as phenotypic switching. SAPs 1, 2, and 3 are expressed only in yeast cells, whereas SAP4-6 expression is confined to hyphae (12, 15); SAP1 and SAP3 expression is correlated with only one switch phenotype (12, 15). In the case of SAPs 4, 5, and 6, only mRNA synthesis, and not Sap protein synthesis has been demonstrated in hyphae; Sap7 expression has never been detected in the laboratory at either the mRNA or protein level.

Based on a comparison of the gene and mature protein sequences, it appears that all Sap enzymes are processed from a larger prepropeptide. The predicted amino-terminal portion of each Sap encodes a secretory hydrophobic leader sequence followed by a proregion, which probably maintains the protein in an inactive state. All of the Saps contain one or more consensus propeptide processing sites ending in the dipeptide Lys-Arg (16). These sites have been directly shown to be involved in the scission of Saps 1, 2, and 3 (17, 18). Cleavage of proproteins at the carboxyl-terminal side of Lys-Arg residues is characteristic of a family of related, subtilisin-type serine proteinases referred to as proprotein convertases (19). The prototype of these processing enzymes is the Kex2 proteinase of Saccharomyces cerevisiae, an enzyme involved in the activation of a secreted pheromone (alpha -mating factor) and a virally encoded killer toxin (20). A number of metazoan secretory products, including prohormones, serum proteins, and neuropeptides are converted into a biologically active form by related proprotein convertases.

Assessment of the role of aspartyl proteinases in the virulence C. albicans is complicated by the multiplicity of genes that encode the proteinases and the complexity and incongruence of their expression patterns in vitro and in vivo. Since these aspartyl proteinases are likely to be processed by a proprotein convertase-like activity, we sought to identify and genetically characterize the C. albicans KEX2-like proteinase. Given the existence of other secreted and cell surface proteins in C. albicans that contain similar Lys-Arg dipeptide proprotein cleavage sites (21, 22), it was possible that genetic ablation of KEX2 activity might have pleiotropic effects on C. albicans.


EXPERIMENTAL PROCEDURES

Media, Yeast Strains, and Plasmids

Strains of Saccharomyces and Candida used are listed in Table I. The yeasts were grown in standard media used for genetic studies of S. cerevisiae (27, 28). C. albicans proteinase secretion was induced as described (29); organisms were grown at 25 °C to prevent the formation of hyphae. Plate assays for proteinase production incorporated 1% agarose in the standard media and were enhanced by staining with 0.1% Amido Black in acetic acid/methanol/H2O (10:25:65), followed by destaining in acetic acid/methanol/water. For hyphal induction, cells were grown for 3 days in YEPD, washed in water, then incubated at 37 °C for 6 h in either RPMI 1640 or YEPD containing 5% fetal calf serum (Life Technologies, Inc.).

Table I.


Strain Genotype Reference

S. cerevisiae
  XBH16-15A MATalpha kex2ade2-1his-leu2-3, 112trp1-289 ura3-52[KIL-K] (20)
  XBH16-13C MATakex2-1his-leu2-3, 112ura3-52[KILk] (20)
  RC634 MATasst1-3ade2his6met1rme1 (20)
  DC17 MATalpha his1[KIL-O] (20)
  BFY106-4C MATacan1-100ade2-1ochis3-11, -15leu2-3, 112trp1-1 ura3-1 kex2 Delta 2::HIS3-A (23)
  BFY106-4D MATalpha can1-100ade2-1ochis3-11, -15leu2-3, 112trp1-1 ura3-1 kex2 Delta 2::HIS3-A (23)
C. albicans
  WO-1 High frequency switching strain (24)
  SC5314 Isolate from blood (25)
  CAI4  Delta ura3::imm434/Delta ura3::imm434 (26)
  CNA1  Delta ura3::imm434/Delta ura3::imm434KEX2kex2::hisGURA3hisG This work
  CNA2  Delta ura3::imm434/Delta ura3::imm434KEX2kex2::hisG This work
  CNA3  Delta ura3::imm434/Delta ura3::imm434kex2::hisGkex2::hisGURA3hisG This work
  CNA4  Delta ura3::imm434/Delta ura3::imm434kex2::hisGkex2::hisG This work

The S. cerevisiae KEX2 gene cloned into the plasmid vector YCp50 (30) was provided by J. Thorner (University of California, Berkeley). YCp19 (31) used to construct a C. albicans strain WO-1 genomic library was obtained from the American Type Culture Collection. The cloned C. albicans KEX2 gene (Fig. 1) was used to (a) generate deletion mutants that no longer complemented the kex2 defect in S. cerevisiae, (b) provide an episomal vehicle for introducing the intact gene back into C. albicans, and (c) prepare a construct for deleting, by homologous recombination, part of the gene in C. albicans. To construct functionally inactive deletion mutants of the C. albicans KEX2, a 5-kb BamHI/SalI fragment was subcloned into pBluescript; the resulting plasmid, pCK1, was then cut with HindIII to remove an internal 350-bp fragment, and ligated to itself to create pCK2. After digestion of pCK2 with BamHI and SalI, its insert was subcloned into similarly cut YCp19. For the purposes of introducing a new copy of KEX2 into C. albicans, pCK1 was linearized with SalI and ligated to a SalI fragment of plasmid pRM10 (32) to form pCK3.


Fig. 1. Restriction map of the C. albicans KEX2 gene. Restriction sites used in making various constructs are indicated as: Bm (BamHI), Bg (BglII), H (HindIII), Sa (SalI), Sp (SpeI), Xb (XbaI), and Xh (XhoI). A represents the relative positions of a portion of the coding region of C. albicans YTP1 gene and of the complete KEX2 gene (in white), with the black bar representing noncoding regions. The gray bar represents part of the tetracyclin resistance gene from vector YCp19, beginning at the Sau3A cloning site (where the black and the gray bars meet). Below the map, indicated by arrowheads, are the relative positions of the active site aspartate (D), histidine (H), asparagine (N), and serine (S) residues. B represents the relative positions of the genes found in the ura-blaster cassette. The KEXD disruption cassette used in the present study consisted of the XhoI-SpeI fragment of KEX2, with the internal 341-bp HindIII fragment being replaced by the ura-blaster cassette.

[View Larger Version of this Image (8K GIF file)]


Nucleic Acid Manipulations

Standard procedures were used for cloning and subcloning of DNA fragments (28). Restriction/modification enzymes were purchased from New England Biolabs and used according to the manufacturer's recommendations. Deoxyribonucleotide stocks were purchased from Boehringer Mannheim. Recombinant plasmids were maintained in E. coli XL1 Blue (Stratagene). DNA sequence analysis of C. albicans KEX2 was determined by automated sequencing by the UCSF Biomedical Resource Center. Sequence comparisons against a non-redundant protein data base were performed by access to NCBI using the BLAST method (33).

Cloning of the C. albicans KEX2 Gene by Complementation

The secretion of biologically active alpha -factor was used as a positive screen for complementation of the S. cerevisiae kex2 mutation (20). Sau3A partial digests (6-20 kb) of WO strain C. albicans DNA were subcloned into the BamHI site of YCp19 (31). The resulting library was used to transform S. cerevisiae strain BFY106-4D; after 2 days of growth in synthetic media lacking uracil, the colonies were replica-plated over a lawn of S. cerevisiae strain RC634 (a MATa strain supersensitive to alpha -factor) grown on YEPD agar, 100 mM sodium citrate, pH 4.5, 0.03% methylene blue. Colonies producing a clear halo, due to pheromone-induced growth arrest, were re-streaked to yield individual colonies and tested again for the phenotype. Plasmids isolated from these colonies were used to transform E. coli XL1 Blue and reisolated, and individual plasmids were re-tested for their ability to restore alpha -factor secretion. As a secondary screen for complementation of the kex2 deficiency, the plasmids isolated above were assayed for their ability to restore killer factor secretion in kex2 KIL-K cells (20).

Production of C. albicans kex2 Strains

The two C. albicans KEX2 alleles were sequentially disrupted by the ura-blaster method (34), as adapted for use in Candida (26). A 2-kb fragment resulting from the digestion of pCK1 with XhoI and SpeI (Fig. 1) was subcloned into the same sites of pBluescript. This plasmid was then digested with HindIII to release a 350-bp fragment, treated with the Klenow fragment of E. coli RNA polymerase I in the presence of all four deoxyrobonucleotides, then dephosphorylated with calf intestinal alkaline phosphatase. The HindIII fragment was replaced by a similarly blunt-ended SalI/BglII fragment of pMB7, which contains the C. albicans URA3 gene flanked by direct repeats of Salmonella hisG DNA (26), in the process eliminating all HindIII sites. The plasmid was then cut with SpeI and XhoI, and the insert (KEXD) was isolated by agarose gel electrophoresis and electroelution. C. albicans strain CAI4 was grown in 100 ml of YEPDA (adenine at 20 µg/ml) to a density of 1-3 × 107 cells/ml and transformed with KEXD by electroporation (35). Digests of DNA from Ura+ colonies were electrophoresed, and analyzed by Southern hybridization to assess the integrity of the KEX2 alleles; an XbaI/SpeI fragment of the the cloned KEX2 gene (Fig. 1) was randomly labeled with 32P and used as the probe. Colonies having the desired disruption were then grown in the presence of 5-fluoroorotic acid, to select for cells where the hisG repeats recombined, deleting the URA3 gene in the process; these ura3 cells were then transformed again with the same KEXD cassette.

SDS-Polyacrylamide Gel Electrophoresis Immunoblotting and Protein Sequencing

Culture supernatants were assayed for the presence of proteinase as described (15). For NH2-terminal amino acid sequencing, supernatants were concentrated by ultrafiltration, electrophoresed, then blotted onto PVDF membranes. Amino-terminal sequencing was performed by the UCSF Biomolecular Resource Center.


RESULTS

Complementation of alpha  Factor and Killer Toxin Secretion in S. cerevisiae Mutants

Southern hybridizations of C. albicans genomic DNA with the cloned S. cerevisiae KEX2 gene failed to detect a C. albicans KEX2 homologue. Taking advantage of the role of Kex2 in S. cerevisiae in the production of active alpha -factor in haploid mating type alpha cells and in the production of a virally encoded killer toxin, we proceeded to isolate the C. albicans gene by complementation of function. Four of 10,000 transformants selected on the basis of ability to grow in the absence of uracil produced a slight halo over a lawn of sst1 cells (Fig. 2). Plasmids isolated from each of the four transformant clones contained a DNA insert of approximately 5 kb having the same restriction map. One of these plasmids (designated as pCK4) was further characterized by retesting in S. cerevisiae BFY106-4D and confirmed to complement the alpha -factor processing defect. As a control for the specificity of the observed phenotype, the plasmid was introduced into mating type a kex2 cells. In this case, no halo was observed, indicating that there was no unspecific growth-arresting phenotype associated with the C. albicans DNA sequence (Fig. 2). When spotted on a lawn of S. cerevisiae sst1 cells, C. albicans did not produce a halo. When introduced into a kex2, mating type alpha  killer strain of S. cerevisiae, pCK4 also restored its ability to lyse neighboring sensitive cells (Fig. 2). Again, C. albicans did not demonstrate the same phenotype (Fig. 2B).


Fig. 2. Complementation of S. cerevisiae KEX2 deletion by C. albicans KEX2. A, secretion of biologically active alpha -factor. Individual colonies were spotted onto a lawn of RC634, a MATa strain that undergoes cell cycle arrest in the presence of alpha -factor. Top row depicts MATalpha kex2 S. cerevisiae strain BFY104-4D with no plasmid (a), with YCp19 (b), with YCp50 containing the S. cerevisiae KEX2 gene (c), and with YCp19 containing the C. albicans KEX2 gene (d). Middle row: BFY106-4D containing the C. albicans KEX2 gene lacking the internal 341-bp HindIII fragment encoding the region surrounding the active site serine (e), MATa kex2 S. cerevisiae strain BFY106-4C with no plasmid (f), BFY106-4C with YCp19 (g), and BFY1064C with S. cerevisiae KEX2 cloned into YCp50 (h). Bottom row: strain BFY106-4C containing the C. albicans KEX2 gene cloned into YCp19 (i) and C. albicans strain SC5314 (j). B, killer toxin secretion. The cells were spotted over a lawn of the killer toxin-sensitive strain DC17. Top row: S. cerevisiae kex2 KIL-K strain XBH16-15A with no plasmid (a), with YCp19 (b), with S. cerevisiae KEX2 cloned into YCp50 (c), and with the C. albicans KEX2 cloned into YCp19 (d). Bottom row: XBH16-15A containing the C. albicans KEX2 gene lacking the 341-bp HindIII fragment and cloned into YCp19 (e), and C. albicans strain SC5314 (f).

[View Larger Version of this Image (88K GIF file)]


Sequence Analysis

The 5-kb insert was subcloned into pBluescript, and sequence analysis from the BamHI site revealed an open reading frame, which, upon translation, yielded an amino acid sequence showing 70% identity over 37 residues with Ytp1p, a hypothetical transmembrane protein of S. cerevisiae. In S. cerevisiae, this gene is located between SIN4 (TSF3) and KEX2 (36). Sequencing from the 3' end of the XhoI site (Fig. 1), a second open reading frame was encountered that encodes a predicted amino acid sequence homologous to S. cerevisiae KEX2, as well as related KEX2 sequences in Yarrowia lipolytica, Kluyveromyces lactis, and Schizosaccharomyces pombe, and to the proconvertases of metazoan species. The predicted translation product (924 amino acids) of the cloned C. albicans gene (Fig. 3) indicates that the encoded protein shares seven domains with its yeast counterparts: 1) an amino-terminal signal sequence terminating at Leu19, 2) an ensuing proregion with two Lys-Arg sites for probable autocatalytic cleavage, the latter ending at Arg129, 3) a catalytic domain characteristic of subtilisin-type serine proteases, with the active site Asp, His, Asn, and Ser residues in appropriate register, 4) a P domain that extends from Lys477 to Glu644, important in autocatalytic removal of the proregion (37), followed by 5) a region rich in serine and threonine residues containing a potential Lys-Arg cleavage site prior to Asp528, 6) a transmembrane domain extending from Tyr773 to Val792, and 7) at the carboxyl terminus, a highly charged cytoplasmic tail that contains the tetrapeptide YEFD, which in S. cerevisiae is important in ensuring retention in the Golgi (38). The predicted protein has five sites for potential N-linked glycosylation, these being located in the proregion, at the amino- and carboxyl-terminal ends of the catalytic domain, and in the Ser/Thr-rich region. ClustalW comparison (39) of the C. albicans and S. cerevisiae KEX2 products indicates that the difference in length between the two proteins (924 versus 814 amino acids, respectively) is due to an insertion immediately following the second predicted Lys-Arg cleavage site, a longer Ser/Thr-rich domain, and a longer cytoplasmic tail. The predicted extensions in the C. albicans protein are also noted in Y. lipolytica Xrp6 (976 amino acids), but not in Kex1 of K. lactis (700 amino acids) or in Krp1 of S. pombe (709 amino acids). Similar analyses indicated that differences in size between S. cerevisiae, K. lactis, and S. pombe proteins are largely due to additions/deletions in these same regions, with the serine/threonine-rich domain demonstrating the most variability. Comparison of the C. albicans KEX2 product with that of S. cerevisiae indicates that the most conserved domain is the catalytic one, where 65% identity and 74% similarity was observed.


Fig. 3. Sequence analysis of the C. albicans KEX2 gene. The predicted translational product of the cloned gene is shown with features discussed in the text being highlighted. The active site residues (DHNS) are denoted by asterisks (*), possible dibasic processing sites are indicated by an underline, potential sites for N-linked glucosylation are denoted by a delta (Delta ), the P region is indicated by >> , and the transmembrane domain is indicate by carets. The serine threonine stretch lies between P region and the transmembrane domain, and the cytosolic tail, containing a probable TGN retention sequence (""), follows the transmembrane domain. The sequence depicted extends from the XbaI to the Sau3A sites indicated in Fig. 1.

[View Larger Version of this Image (84K GIF file)]


Genetic Inactivation of C. albicans KEX2

In the deletion construct KEXD described under "Experimental Procedures," the active site serine was deleted (Figs. 1 and 3). To assure that the deletion of the internal HindIII fragment of KEX2 inactivated its function, S. cerevisiae strain BFY106-4D was transformed with pCK2, a plasmid that contains C. albicans KEX2 without the HindIII fragment. Plasmid pCK2 did not restore the ability of alpha  cells to make alpha -factor, killer toxin, or, by inference, active Kex2 (Fig. 2).

Transformation of C. albicans CAI4 with the KEXD cassette yielded 10 Ura+ colonies, each of which were analyzed by Southern hybridization (Fig. 4); all contained the construct inserted in the genome by homologous recombination at one of the two KEX2 alleles; 1 of the 10 colonies had multiple tandem insertions. A strain with a single copy of the desired insertion, designated CNA1, was treated with 5-fluoroorotic acid (5-FOA) to select against the Ura+ phenotype. As a result, strain CNA2 was formed, representing the knockout of a single allele of KEX2 (Fig. 4). In the process, a single copy of hisG was left behind at the deleted locus as confirmed by Southern hybridization (Fig. 4). The CNA2 strain, containing a single disrupted allele of KEX2 was then transformed with the same KEXD cassette. Approximately 200 Ura+ colonies were obtained in the second round of transformation. Roughly 1/20 of the transformants examined by Southern analysis contained two disrupted kex2 alleles, one with a single copy of hisG and the other with the hisG-URA3-hisG cassette (Fig. 4). One of these double knockout strains was designed CNA3 and was again treated with 5-FOA to generate the final null mutation strain CNA4, which is both kex2 and ura3 (Fig. 4).


Fig. 4. Sequential disruption of the C. albicans KEX2 gene. Genomic DNA of C. albicans strains was digested with HindIII and probed with the entire sequence shown in Fig. 3. DNA was prepared from the following strains: lane 1, wild type SC5314; lane 2, CAI4, its ura- derivative; lane 3, CNA1, which contains the ura-blaster cassette at one KEX2 locus of CAI4; lane 4, CNA2, a derivative of CNA1 selected for growth on 5-FOA; lane 5, CNA 3, which contains the cassette at the second KEX2 locus; and lane 6, CNA4, a sibling of CNA3 selected on 5-FOA plates. The wild type strain has 6.4- and 4.0-kb regions flanking each end of the internal HindII sites (H), as indicated in the diagram on the right. Replacement of the 341-bp fragment encoding amino acids that include the active site serine with the URA3 containing fragment eliminates the HindIII site. In lane 3, the upper band represents the flanks plus the ura-blaster: 6.4 kb + 4.0 kb + 3.8 kb (from ura-blaster) = 14.2 kb. In lane 4, the lower band drops by about 2.7 kb due to the loss of ura3 and one hisG unit. In lane 5, the second allele has been affected, hence the loss of the two flanks in the digest. The arrow highlights the 341-bp fragment that was deleted in strains CNA3 and CNA4. The migration of the molecular weight standards is indicated on the left in kilobases.

[View Larger Version of this Image (48K GIF file)]


Effects of kex2 Mutation on Proteinase Secretion

Although the regulation of the SAP gene family has been widely studied in WO and 3153 cells, little is known about its regulation in other strains including the parent strain SC5314 or its Ura+ derivative, CAI4, commonly used for mutational analysis in C. albicans (26). When grown in proteinase-inducing liquid media under conditions that do not simultaneously stimulate hyphal development, C. albicans strains SC5314 and CAI4 both produced a single Sap isoenzyme, which is equivalent to Sap2 based on electrophoretic mobility (Fig. 5) and Northern analyses (data not shown). In other C. albicans strains, the expression of Saps 4-6 is inferred from the appearance of their respective mRNAs in hyphae grown under inducing conditions (12, 15); however, Sap 4, 5, and 6 polypeptides have never been specifically detected in any C. albicans strain. The antibody used in the present study cross-reacts with Saps 1-3, but it is not known whether it will react with other Saps; however, Coomassie-stained gels yielded a single band. We thus confined our analyses of C. albicans Sap secretion to Sap production in yeast forms of the organism. When seeded in proteinase-inducing medium at a similar density, the parent strains SC5314 and CAI4 and the knockout strains CNA1 and CNA3 grew at different rates, with CNA3 (kex2/kex2) growing the slowest.


Fig. 5. Immunoblot analyses of Saps secreted by strains of C. albicans into the media. Supernatants were electrophoresed, blotted, and probed with anti-Sap2 antibody. A, Sap secretion after 24 h in inducing media. Lane 1, a mix of three proteinases secreted by strain WO-1; lane 2, SC5314; lane 3, CNA1 (KEX2/kex2); lane 4, CNA3 (kex2/kex2); lane 5, CAI4 with plasmid pRM10; lane 6, CNA2 (KEX2/kex2) with pRM10; lane 7, CNA4 (kex2/kex2) with pCK4; lane 8, CNA4 with pRM10. Strains CNA2 and CNA4 are ura- derivatives of CNA1 and CNA3, respectively. Plasmid pRM10 contains the C. albicans URA3, ARS2, and ARS3, and plasmid pCK4 contains the same markers plus the C. albicans KEX2 gene. Strains labeled as ura+ have the URA3 gene integrated into the chromosome, and those labeled ura- do not (URA3 being supplied by a plasmid). B, Saps found in the media after 3 days in inducing media. The labeling of lanes 1-8 is as in A.

[View Larger Version of this Image (47K GIF file)]


Analysis of secreted Saps in the culture medium by SDS-PAGE and Western blotting revealed that at 24 h the wild type and heterozygous CNA1 strains produce a single Sap, Sap2, whereas homozygous kex2 cells produce two antibody-reactive species, one with a faster electrophoretic mobility and another with a slower one than Sap2 (Fig. 5). When the kex2/kex2 strain CNA4 was transformed with a plasmid containing C. albicans KEX2 (pCK3), the antibody-reactive doublet was replaced by a single protein having the same electrophoretic mobility as Sap2; this effect was not seen in CNA4 cells transformed with pRM10 (32), a plasmid lacking KEX2 but having the same markers as pCK3 (Fig. 5). The homozygous knockout strain CNA4 produced less proteinase than the wild type and heterozygous parents, and this effect was only partially corrected by pCK3.

After 2 days of growth, cultures of the wild type and mutant strains had each reached stationary phase. Analysis of proteinase secreted into the medium during this period was similar in result to that at 24 h, with the exception that the slower migrating band noted in the medium of Kex2 heterozygous cells at 24 h was not present after 4 days of growth. When kex2/kex2 cells were transformed with pCK3, but not pRM10, the capacity to produce a Sap consistent in electrophoretic mobility with properly processed Sap2 was restored; however, the double knockout strain still produced the faster migrating species (Fig. 5). Northern analysis of cells grown in media for 24 h indicated that all of the strains produced mRNA for Sap2, but not for Saps 1, 3, or 4-6 (data not shown). Sequencing of the Sap produced by strain CNA3 yielded the following amino-terminal sequence: RQAVP, with a preceding trace consistent with the sequence KTSK, confirming its identity as Sap2.

Activity of Secreted Aspartyl Proteinases

When grown on plates for 24-48 h with bovine serum albumin as the only significant nitrogen source, kex2/kex2 cells reproducibly secreted less, or less active, proteinase than wild type or heterozygous cells, as determined by the size of the halos of hydrolyzed substrate surrounding the colonies (Fig. 6). However, after 1 week of growth on solid medium, the zones of clearing surrounding kex2/kex2 cells approximated that of wild type cells. This pattern is consistent with the interpretation that the wild type cells reach stationary phase more rapidly than the double knockout strain.


Fig. 6. Protease production by C. albicans strains grown on albumin plates. A, protease secretion 24 h after plating. Top row, from left to right: a, SC5314; b, CNA1 (KEX2/kex2); c, CNA3 (kex2/kex2). Middle row: d, CAI4 with plasmid pRM10; e, CNA2 (KEX2/kex2) with pRM10; f, CNA4 (kex2/kex2) with pRM10. Bottom row: g, CNA4 with pCK4 (which contains KEX2). B, proteinase secretion after 2 days on plates. The labeling is the same as in A. C, proteinase production 1 week after plating. Top row, SC5314 and CNA1; bottom row, CNA3 and CNA4 harboring pCK4. D, magnification of the edges of colonies shown on C of SC5314 (a), CNA1 (b), CNA3 (c), and CNA4 (d) containing KEX2 on a plasmid pCK4.

[View Larger Version of this Image (120K GIF file)]


Morphogenesis of C. albicans kex2 Cells

When left on albumin-containing media for over 10 days, the edge of the colonies of kex2/kex2 cells was smoother in comparison to that of wild type cells. Microscopic examination revealed that the difference was a result of the failure of the homozygous kex2 strain to give rise to hyphae, although they retained the ability to form pseudohyphae and invade the agar substratum (Fig. 6). When grown in RPMI 1640 or in YEPD plus serum at 37 °C, the wild type cells and heterozygous KEX2/kex2 cells both produced germ tubes within 2 h and became almost uniformly hyphal forms within 6 h (Fig. 7). Homozygous kex2/kex2 cells failed to produce hyphae under the same conditions, even after 24 h of induction; instead, the cells were enlarged, aberrantly shaped, often had multiple buds, tended to aggregate, and often had multiple nuclei. When grown in minimal media or in RPMI 1640 at 25 °C, all of the strains grew as yeast cells. Staining kex2/kex2 cells grown under hyphae-inducing conditions with calcofluor white indicated that chitin deposition, normally most intensely focused on sites of budding, in bud scars, and in septae between cells was more intense than in the wild type cells and delocalized (Fig. 7). The morphological defects noted in kex2/kex2 CNA4 cells were largely reversed when the strain was transformed with a plasmid containing KEX2 (Fig. 7).


Fig. 7. Morphology of kex2 strains grown under hyphal-inducing conditions. The cells were grown in RMPI 1640 at 37 °C; similar morphologies were noted for cells of each of the respective strains grown in the presence of serum (data not shown). Represented are the wild type SC5314 (A), heterozygous KEX2 mutant CNA1 (B), the double knockout strain CNA3 (C), and strain CNA4 containing the Candida KEX2 gene on an episome (D). Strains SC5314 (E) and CNA3 (F) were stained with calcofluor white (40). Note that in the wild type cells, the stain is most intense at the septae, whereas in strain CNA3 the staining is more uneven, focal deposits being sometimes found at regions between cells, at bud scars, and in cell extensions. Cells were prepared for microscopy by fixing with 4% formaldehyde in PBS (pH 7.4) for 4 h, followed by two washes with PBS; they were stored at 4 °C and photographed with a Nikon FM2 mounted on a Zeiss Axioplan fluorescent microscope.

[View Larger Version of this Image (174K GIF file)]



DISCUSSION

Sequence analysis of the C. albicans gene described in the present study indicates that it encodes a type 1 transmembrane protein homologous to Kex2 of S. cerevisiae (41), Xpr6 of Y. lipolytica (42), Krp1 of S. pombe (43), and Kex1 of K. lactis (44), and to a subset of subtilisin-related proprotein convertases of higher eukaryotes (19). Based on its amino acid sequence, the C. albicans Kex2 protease is likely to exist as an active form in the trans-Golgi (TGN) network, with the catalytic domain being located in the lumen and the short, highly charged carboxyl-terminal region facing the cytoplasm. The tetrapeptide, YEFD, necessary for the maintenance of Kex2 in the TGN of S. cerevisiae (38) is perfectly conserved in the predicted cytoplasmic domain of the C. albicans protein. In the TGN, C. albicans Kex2 would thus be in a position to interact with the Candida Saps, which based on biochemical, ultrastructural, and genetic criteria appear to transit through the yeast classical secretory pathway (45, 46).

Results of the present study indicate that Sap2 secretion by C. albicans strain SC5314 involves a Kex2-dependent processing event, but that the aspartyl proteinase can also be activated by an alternative pathway not appreciably expressed by wild type cells. Sap2 is normally processed after the dipeptide KR, but in the absence of Kex2 processing occurs after the R, yielding an amino terminus that is 1 amino acid longer; whether additional processing events occur at the carboxyl terminus remains possible, but atypical electrophoretic characteristics of fungal aspartyl proteinases has been noted in previous studies (18). The alternative processing of Sap2 in kex2 C. albicans may involve either (a) activation by another proteinase or (b) autocatalysis. With respect to the first possibility, it is conceivable that as Sap2 is secreted, it is cleaved by as yet to be established homologues of S. cerevisiae Mkc7 or Yap3, membrane-associated aspartyl proteinases that when overexpressed suppress some kex2 phenotypes (47). However, these enzymes appear to have a similar specificity as Kex2 and would not be expected to yield the lower molecular weight Sap2 product noted in kex2/kex2 cells. We are unaware of the existence of any other active proteinase that Sap2 would encounter during its transit from the endoplasmic reticulum to the outside of the cell. As for the second possibility, the observation that precursors present in the medium after 1 day in culture are no longer evident on day 4 is consistent with autocatalysis. Several secretory aspartyl proteinases of fungal origin have been noted to mature when placed under acidic conditions, self-activation apparently involving intra- and intermolecular interactions dependent on the presence of a lysine residue near the cleavage site (48). More closely related to the present study, a recombinant form of the proenzyme of a C. tropicalis Sapt1, a homologue of C. albicans Saps, has been demonstrated to process itself when placed under acidic conditions (49). The C. tropicalis enzyme can also be autocatalytically activated when produced in S. cerevisiae under conditions where one of its Kex2 processing sites are mutated; however, in this instance the product is 4 amino acids longer than the expected mature form (46). Removal of the Lys-Arg sequence immediately preceding the mature form of Sapt1 results in reduced secretion and possibly reduced activity of the enzyme, leading to an inability of C. tropicalis to grow in the presence of bovine serum albumin as a sole nitrogen source (46). Similarly, Y. lipolytica deficient in the kexin Xpr6, secrete an unprocessed and essentially inactive Kex2-dependent alkaline serine proteinase (42). As is the case with C. tropicalis, we found that efficient secretion of Sap2 is Kex2-dependent in C. albicans. Unlike the homologue in C tropicalis, however, the abnormally processed enzyme has activity sufficient to sustain viability of C. albicans grown under conditions where bovine serum albumin is the sole source of amino acids.

In addition to influencing Sap production, the double KEX2 mutation affected morphogenesis. When grown under conditions that induce hyphal development, strain CNA3 became clearly distinct in shape from both yeast and hyphal forms. The cells tended to be larger than yeast forms, often possessed multiple buds, and formed short extensions that were occasionally bent and appeared as thicker than normal germ tubes that stained erratically with calcofluor white. Morphological defects due to KEX2 mutations have been described for Y. lipolytica (42) and S. cerevisiae (47). In the first instance, these consist of the formation of larger more elongated cells than usual that remain attached after budding. In the second, the phenotype is temperature-dependent such that cells grown at 16 °C are considerably larger than the wild type and often contain multiple buds (47). Deformations in S. cerevisiae kex2 cells appear to be associated with abnormal patterns of chitin deposition, as demonstrated by calcofluor staining patterns. Our results with C. albicans are consistent with this finding.

The molecular basis of the atypical morphology of null kex2 C. albicans grown under hyphae-inducing conditions is unclear; however, possibilities include: 1) a defect in cell wall formation, 2) interference with a direct role of Saps in cell wall remodeling, or 3) an effect on cell polarity. To date, two C. albicans cell wall components have been identified that, based on DNA sequence analysis, would appear to require Kex2 processing: an exo-beta -(1, 3)-glucanase (21) and Hwp1, a hyphal cell wall-associated protein consisting of tandemly repeated proline- and glutamine-rich amino acid motifs (22). In S. cerevisiae, single or double disruptions of EXG1 and EXG2, which encode exoglucanases, are phenotypically neutral (50); however, this organism does not form true hyphae. It should be noted that the kex2 strains developed in the present study were able to form pseudohyphae and to display invasive behavior on agar plates. Of possible relevance, deletion of a family of Kex2-processed hydrophobic cell wall proteins of inactivation of Ustilago maydis results in an inability to form aerial hyphae (51); C. albicans homologues have not been described, although several hydrophobic cell wall proteins have been identified at the biochemical level (52). In S. cerevisiae, cell wall components that appear to require Kex2-dependent processing have been described (53), but their function is currently unknown; the inability of kex2 S. cerevisiae to sporulate due to a defect at the late stages of meiosis has been tentatively ascribed to abnormal cell wall metabolism (54). As for the second possibility, secretory aspartyl proteinases of aspergilli have been suggested to play a direct role in cell wall formation, perhaps by reorganizing the architecture of the growing hyphal tip (55). As for the last possibility, defects in kex2 S. cerevisiae grown at 16 °C are consistent with a defect in polarized growth, as inferred from de-localization of cortical actin patches in affected cells (47).

Results of the present study indicate that disruption of Kex2 function in C. albicans has pleiotropic effects that may impinge on the ability of the organism to colonize and invade tissues. Whether the lowered capacity of kex2 C. albicans to secrete aspartyl proteinases and form true hyphae affects the ability of the organism to cause disease under opportunistic conditions remains to be demonstrated. If so, it may be possible to test whether peptide-based kexin inhibitors being developed for anti-viral purposes (56) have anti-fungal properties. This line of investigation may be facilitated by the observation that, unlike S. cerevisiae, C. albicans has a specific oligopeptide transport system that can accommodate pentamers and hexamers (57).


FOOTNOTES

*   This work was supported by National Institutes of Health Grants PO1 DE07946 (to N. A. and the University of California at San Francisco Oral AIDS Center) and RO1 A133317 (to N. A.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
par    To whom correspondence should be addressed: Dept. of Stomatology, University of California at San Francisco, Box 0422, San Francisco, CA 94143-0422. Tel.: 415-476-6845/6850; Fax: 415-476-0664.
1   The abbreviations used are: Sap, C. albicans secreted aspartyl proteinase; YEPD, yeast extract-peptone-dextrose; YEPDA, yeast extract-peptone-dextrose-adenine; TGN, trans-Golgi network; PVDF, polyvinylidene difluoride; 5-FOA, 5-fluoroorotic acid; kb, kilobase pair(s); bp, base pair(s).

ACKNOWLEDGEMENTS

We thank Fang Feng for technical assistance and A. Kuo for timely and constructive suggestions. We also extend our appreciation to D. Soll for provision of the WO-1 strain of C. albicans, W. Fonzi for strains C5314 and CAI4 and plasmid pMB7, C. Nombela for plasmid pRM10, and C. Inouye and J. Thorner for the S. cerevisiae strains and KEX2 plasmid.


REFERENCES

  1. Odds, F. C. (1988) Candida and Candidosis, Balliere Tindal, London
  2. De Bernardis, F., Chiani, P., Ciccozzi, M., Pellegrini, G., Ceddia, T., D'Offizzi, G., Quinti, I., Sullivan, P. A., and Cassone, A. (1996) Infect. Immun. 64, 466-471 [Abstract]
  3. Ollert, M. W., Wende, C., Gorlich, M., McMullan-Vogel, C. G., Borg-von Zepelin, M., Vogel, C.-W., and Korting, H. C. (1995) J. Clin. Microbiol. 33, 2543-2549 [Abstract]
  4. Wu, T., Samaranayake, L. P., Cao, B. Y., and Wang, J. (1996) J. Med. Microbiol. 44, 311-316 [Abstract/Free Full Text]
  5. Jones, S., White, G., and Hunter, P. R. (1994) J. Clin. Microbiol. 32, 2869-2870 [Abstract/Free Full Text]
  6. Sweet, S. P., Cookson, S., and Challacombe, S. J. (1995) J. Med. Microbiol. 43, 452-457 [Abstract/Free Full Text]
  7. Ollert, M. W., Sohnchen, R., Korting, H. C., Ollert, U., Brautigam, S., and Brautigam, W. (1993) Infect. Immun. 61, 4560-4568 [Abstract/Free Full Text]
  8. Pfaller, M. A., Rhine-Chalberg, J., Redding, S. W., Smith, J., Farinacci, G., Fothergill, A. W., and Rinaldi, M. G. (1995) J. Clin. Microbiol. 32, 59-64 [Abstract/Free Full Text]
  9. Agabian, N., Odds, F. C., Poulain, D., Soll, D. R., and White, T. C. (1994) J. Med. Vet. Mycol. 32, (Suppl. I), 229-237
  10. Ruchel, R., De Bernardis, F., Ray, T. L., Sullivan, P. A., and Cole, G. T. (1992) J. Med. Vet. Mycol. 30 (Suppl. 1), 123-132
  11. Hoegl, L., Ollert, M., and Korting, H. C. (1996) J. Mol. Med. 74, 135-142 [CrossRef][Medline] [Order article via Infotrieve]
  12. Hube, B., Monod, M., Schofield, D. A., Brown, J. P., and Gow, N. A. R. (1994) Mol. Microbiol. 14, 87-99 [CrossRef][Medline] [Order article via Infotrieve]
  13. Staib, F. (1965) Sabouraudia 4, 187-193 [Medline] [Order article via Infotrieve]
  14. Cutfield, S. M., Dodson, E. J., Anderson, B. F., Moody, P. C., Marshall, C, J., Sullivan, P. A., and Cutfield, J. F. (1995) Structure 3, 1261-1271 [Medline] [Order article via Infotrieve]
  15. White, T. C., and Agabian, N. (1995) J. Bacteriol. 177, 5215-5221 [Abstract/Free Full Text]
  16. Monod, M., Togni, G., Hube, B., and Sanglard, D. (1994) Mol. Microbiol. 13, 357-368 [CrossRef][Medline] [Order article via Infotrieve]
  17. Morrison, C. J., Hurst, S. F., Bragg, S. L., Kuykendall, R. J., Diaz, H., Pohl, J., and Reiss, E. (1993) Infect. Immun. 61, 2030-2036 [Abstract/Free Full Text]
  18. White, T. C., Miyasaki, S, H., and Agabian, N. (1993) J. Bacteriol. 175, 6126-66133 [Abstract/Free Full Text]
  19. Seidah, N. G., Chretien, M., and Day, R. (1994) Biochimie 76, 197-209 [Medline] [Order article via Infotrieve]
  20. Julius, D., Brake, A., Blair, L., Kunisawa, R., and Thorner, J. (1984) Cell 37, 1075-1089 [CrossRef][Medline] [Order article via Infotrieve]
  21. Chambers, R. S., Broughton, M. J., Cannon, R. D., Carne, A., Emerson, G. W., and Sullivan, P. A. (1993) J. Gen. Microbiol. 139, 325-334 [Abstract/Free Full Text]
  22. Staab, J. F., Ferrer, CA., and Sundstrom, P. (1996) J. Biol. Chem. 271, 6298-6305 [Abstract/Free Full Text]
  23. Wilcox, C. A., and Fuller, R. S. (1991) J. Cell Biol. 115, 297-307 [Abstract/Free Full Text]
  24. Slutsky, B., Buffo, J., and Soll, D. R. (1985) Science 230, 666-669 [Abstract/Free Full Text]
  25. Gillum, A. M., Tsay, E. Y. H., and Kirsch, D. R. (1984) Mol. Gen. Genet 198, 179-182 [CrossRef][Medline] [Order article via Infotrieve]
  26. Fonzi, W. A., and Irwin, M. Y. (1993) Genetics 134, 717-728 [Abstract]
  27. Rose, M. D., Winston, F., and Hieter, P. (1990) Methods in Yeast Genetics: A Laboratory Course Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  28. Ausubel, F. A., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K. (eds) (1996) Current Protocols in Molecular Biology, John Wiley & Sons, New York
  29. Crandall, M., and Edwards, J. E., Jr. (1987) J. Gen. Microbiol. 133, 2817-2824 [Abstract/Free Full Text]
  30. Rose, M. D., Novick, P., Thomas, J. H., Botstein, D., and Fink, G. R. (1987) Gene (Amst.) 60, 237-243 [CrossRef][Medline] [Order article via Infotrieve]
  31. Stinchcomb, D. T., Mann, C., and Davis, R. W. (1982) J. Mol. Biol. 158, 157-190 [CrossRef][Medline] [Order article via Infotrieve]
  32. Pla, J., Perez-Diaz, R. M., Navarro-Garcia, F., Sanchez, M., and Nombela, C. (1995) Gene (Amst.) 165, 115-120 [CrossRef][Medline] [Order article via Infotrieve]
  33. Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J. (1990) J. Mol. Biol. 215, 403-410 [CrossRef][Medline] [Order article via Infotrieve]
  34. Alani, E., Cao, L., and Kleckner, N. (1987) Genetics 166, 541-545
  35. Kohler, G. A., White, T. C., and Agabian, N (1997) J. Bacteriol. 179, 2331-2338 [Abstract/Free Full Text]
  36. West, R. W., Jr., Crivellone, M. D., Ma, J., and Thomas, S. (1996) Gene (Amst.) 169, 119-124 [CrossRef][Medline] [Order article via Infotrieve]
  37. Gluschankov, P., and Fuller, R. S. (1994) EMBO J. 13, 2280-2288 [Medline] [Order article via Infotrieve]
  38. Redding, K., Brickner, J. H., Marschall, L. G., Nichoils, J. W., and Fuller, R. S. (1996) Mol. Cell. Biol. 6, 6208-6217
  39. Thompson, J. D., Higgins, D. G., and Gibson, T. J. (1994) Nucleic Acids Res. 22, 4673-4680 [Abstract/Free Full Text]
  40. Pringle, J. R. (1991) Methods Enzymol. 194, 732-735 [Medline] [Order article via Infotrieve]
  41. Mizuno, K., Nakamura, T., Oshima, T., Tanaka, S., and Matsuo (1988) Biochem. Biophys. Res. Commun. 156, 246-254 [CrossRef][Medline] [Order article via Infotrieve]
  42. Enderlin, C. S., and Ogrydziak, D. M. (1994) Yeast 10, 67-79 [CrossRef][Medline] [Order article via Infotrieve]
  43. Davey, J., Davis, K., Imai, Y., Yamamoto, M., and Matthews, G. (1994) EMBO J. 13, 5910-5921 [Medline] [Order article via Infotrieve]
  44. Tanguy-Rougeaua, C., Wesolowski-Louvel, M., and Fukuhara, H. (1988) FEBS Lett. 234, 464-470 [CrossRef][Medline] [Order article via Infotrieve]
  45. Akashi, T., Homma, M., Kanbe, T., and Tanaka, K. (1993) J. Gen. Microbiol. 139, 2185-2195 [Abstract/Free Full Text]
  46. Togni, G., Sanglard, D., Quadroni, M., Foundling, S. I., and Monod, M. (1996) Microbiology 142, 493-503 [Abstract/Free Full Text]
  47. Komano, H., and Fuller, R. S. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 10752-10756 [Abstract/Free Full Text]
  48. Inoue, H., Hayashi, T., Huang, X.-P., Lu, J. F., Athauda, S. B. P., Kong, K. H., Yamagata, H., Udaka, S., and Takahashi, K. (1996) Eur. J. Biochem. 237, 719-725 [Medline] [Order article via Infotrieve]
  49. Lin, X., Tang, J., Koelsch, G., Monod, M., and Foundling, S. (1993) J. Biol. Chem. 268, 20143-20147 [Abstract/Free Full Text]
  50. Larriba, G., Andaluz, E., Cueva, R., and Basco, R. D (1995) FEMS Microbiol. Lett. 125, 121-126 [CrossRef][Medline] [Order article via Infotrieve]
  51. Wosten, H. A. B., Bohlmann, R., Eckerskorn, C., Lottspeich, F., Bolker, M., and Kahmann, R. (1996) EMBO J. 15, 4274-4281 [Medline] [Order article via Infotrieve]
  52. Glee, P. M., Sundstrom, P., and Hazen, K. C. (1995) Infect. Immun. 63, 1373-1379 [Abstract]
  53. Rogers, D. T., Saville, D., and Bussey, H. (1979) Biochem. Biophys. Res. Commun. 90, 187-193 [CrossRef][Medline] [Order article via Infotrieve]
  54. Leibowitz, M. J., and Wickner, R. B. (1976) Proc. Natl. Acad. Sci. U. S. A. 73, 2061-2065 [Abstract/Free Full Text]
  55. Reichard, U., Monod, M., and Ruchel, R. (1996) Mycoses 39, 99-101 [Medline] [Order article via Infotrieve]
  56. Angliker, H. (1995) J. Med. Chem. 38, 4014-4018 [CrossRef][Medline] [Order article via Infotrieve]
  57. Lubkowitz, M. A., Hauser, L., Breslav, M., Naider, F., and Becker, J. M. (1997) Microbiology 143, 387-396 [Abstract/Free Full Text]

Volume 272, Number 46, Issue of November 14, 1997 pp. 28954-28961
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Microbiol. Mol. Biol. Rev.Home page
W. L. Chaffin
Candida albicans Cell Wall Proteins
Microbiol. Mol. Biol. Rev., September 1, 2008; 72(3): 495 - 544.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
D. Dignard, A. L. El-Naggar, M. E. Logue, G. Butler, and M. Whiteway
Identification and Characterization of MFA1, the Gene Encoding Candida albicans a-Factor Pheromone
Eukaryot. Cell, March 1, 2007; 6(3): 487 - 494.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Albrecht, A. Felk, I. Pichova, J. R. Naglik, M. Schaller, P. de Groot, D. MacCallum, F. C. Odds, W. Schafer, F. Klis, et al.
Glycosylphosphatidylinositol-anchored Proteases of Candida albicans Target Proteins Necessary for Both Cellular Processes and Host-Pathogen Interactions
J. Biol. Chem., January 13, 2006; 281(2): 688 - 694.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
B. L. Granger, M. L. Flenniken, D. A. Davis, A. P. Mitchell, and J. E. Cutler
Yeast wall protein 1 of Candida albicans
Microbiology, May 1, 2005; 151(5): 1631 - 1644.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
S. L. Panwar, M. Legrand, D. Dignard, M. Whiteway, and Paul. T. Magee
MF{alpha}1, the Gene Encoding the {alpha} Mating Pheromone of Candida albicans
Eukaryot. Cell, December 1, 2003; 2(6): 1350 - 1360.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
J. R. Naglik, S. J. Challacombe, and B. Hube
Candida albicans Secreted Aspartyl Proteinases in Virulence and Pathogenesis
Microbiol. Mol. Biol. Rev., September 1, 2003; 67(3): 400 - 428.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
G. E. Palmer, A. Cashmore, and J. Sturtevant
Candida albicans VPS11 Is Required for Vacuole Biogenesis and Germ Tube Formation
Eukaryot. Cell, June 1, 2003; 2(3): 411 - 421.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. X. Cawley, M. Chino, A. Maldonado, Y. M. Rodriguez, Y. P. Loh, and J. A. Ellman
Synthesis and Characterization of the First Potent Inhibitor of Yapsin 1. IMPLICATIONS FOR THE STUDY OF YAPSIN-LIKE ENZYMES
J. Biol. Chem., February 14, 2003; 278(8): 5523 - 5530.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Newport, A. Kuo, A. Flattery, C. Gill, J. J. Blake, M. B. Kurtz, G. K. Abruzzo, and N. Agabian
Inactivation of Kex2p Diminishes the Virulence of Candida albicans
J. Biol. Chem., January 10, 2003; 278(3): 1713 - 1720.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
B. Hube and J. Naglik
Candida albicans proteinases: resolving the mystery of a gene family
Microbiology, August 1, 2001; 147(8): 1997 - 2005.
[Full Text] [PDF]


Home page
J. Bacteriol.Home page
M. Richard, R. R. Quijano, S. Bezzate, F. Bordon-Pallier, and C. Gaillardin
Tagging Morphogenetic Genes by Insertional Mutagenesis in the Yeast Yarrowia lipolytica
J. Bacteriol., May 15, 2001; 183(10): 3098 - 3107.
[Abstract] [Full Text]


Home page
MicrobiologyHome page
M. A. Uhl and A. D. Johnson
Development of Streptococcus thermophilus lacZ as a reporter gene for Candida albicans
Microbiology, May 1, 2001; 147(5): 1189 - 1195.
[Abstract] [Full Text]


Home page
MicrobiologyHome page
S. Beggah, B. Léchenne, U. Reichard,, S. Foundling, and M. Monod
Intra- and intermolecular events direct the propeptide-mediated maturation of the Candida albicans secreted aspartic proteinase Sap1p
Microbiology, November 1, 2000; 146(11): 2765 - 2773.
[Abstract] [Full Text]


Home page
Infect. Immun.Home page
J. R. Naglik, G. Newport, T. C. White, L. L. Fernandes-Naglik, J. S. Greenspan, D. Greenspan, S. P. Sweet, S. J. Challacombe, and N. Agabian
In Vivo Analysis of Secreted Aspartyl Proteinase Expression in Human Oral Candidiasis
Infect. Immun., May 1, 1999; 67(5): 2482 - 2490.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Newport, G.
Right arrow Articles by Agabian, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Newport, G.
Right arrow Articles by Agabian, N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement